Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shionogi Of Japan, U.S. Arm Sciele To Buy Victory Pharma For $150 Million

This article was originally published in PharmAsia News

Executive Summary

Japan's Shionogi, through its U.S. subsidiary Sciele Pharma, plans to buy another U.S. drug maker, Victory Pharma, for $150 million. Sciele plans to complete the acquisition by mid-summer, assuming the merger is cleared by U.S. antitrust authorities. Buying Victory would give Sciele and Shionogi the private company's Naprelan (naproxen) anti-inflammatory drug, a targeted therapeutic area of Shionogi's. Shionogi also said it plans to develop the drug for more indications, including alleviating the adverse effects of opioids and other similar compounds. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071658

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel